So Mr market values us at 4.3c currently given what the Co has announced in the last 2 months or so, interesting:
04/07 - New Study validated pain detection sp 2.5c
19/07 - Epat secures TGA and CE approval sp 3.5c
24/07 - Nviso agrees perpetual global license sp 4.2c
15/08 - Clinical study published in Alzheimers disease journal sp 5.6c
07/09 - Core strategic agreement with DSA sp 7.4c
18/09 - 3.75 mill raised through Insto,family Office and SI placement, funds to be used for commercial roll out in Q4 and FDA approvals sp 5.6c
26/09 - Epat to accelerate commercialisation at Alzheimers conference held mid Oct sp 4.3c
Currently sp 4.3c and approx a full 360 to where we were 2 months ago.
EPT Price at posting:
4.3¢ Sentiment: None Disclosure: Held
